Literature DB >> 29242891

Diagnosis and Treatment of Hypertension in the 2017 ACC/AHA Guidelines and in the Real World.

John P A Ioannidis1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29242891     DOI： 10.1001/jama.2017.19672

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  24 in total

1. 

Authors:  Harminder Singh; James A Dickinson; Guylène Thériault; Roland Grad; Stéphane Groulx; Brenda J Wilson; Olga Szafran; Neil R Bell
Journal:  Can Fam Physician       Date:  2018-09       Impact factor: 3.275

2.  Overdiagnosis: causes and consequences in primary health care.

Authors:  Harminder Singh; James A Dickinson; Guylène Thériault; Roland Grad; Stéphane Groulx; Brenda J Wilson; Olga Szafran; Neil R Bell
Journal:  Can Fam Physician       Date:  2018-09       Impact factor: 3.275

Review 3.  Comparison of the 2017 ACC/AHA Hypertension Guideline with Earlier Guidelines on Estimated Reductions in Cardiovascular Disease.

Authors:  Joshua D Bundy; Katherine T Mills; Jiang He
Journal:  Curr Hypertens Rep       Date:  2019-08-31       Impact factor: 5.369

4.  Physiologically Based Pharmacokinetic Modeling of Fimasartan, Amlodipine, and Hydrochlorothiazide for the Investigation of Drug-Drug Interaction Potentials.

Authors:  Su-Jin Rhee; Hyun A Lee; Soyoung Lee; Eunwoo Kim; Inseung Jeon; Im-Sook Song; Kyung-Sang Yu
Journal:  Pharm Res       Date:  2018-10-15       Impact factor: 4.200

5.  Nutritional Genomics of Cardiovascular Disease.

Authors:  V Saroja Voruganti
Journal:  Curr Genet Med Rep       Date:  2018-04-30

6.  Potential impact of the 2017 ACC/AHA guideline on high blood pressure in normotensive patients with stable coronary artery disease: insights from the CLARIFY registry.

Authors:  Emmanuelle Vidal-Petiot; Emmanuel Sorbets; Deepak L Bhatt; Gregory Ducrocq; Yedid Elbez; Roberto Ferrari; Ian Ford; Jean-Claude Tardif; Michal Tendera; Kim M Fox; Philippe Gabriel Steg
Journal:  Eur Heart J       Date:  2018-11-14       Impact factor: 29.983

7.  Prevalence of Hypertension, Treatment, and Blood Pressure Targets in Canada Associated With the 2017 American College of Cardiology and American Heart Association Blood Pressure Guidelines.

Authors:  Stephanie Garies; Sylvia Hao; Kerry McBrien; Tyler Williamson; Mingkai Peng; Nadia A Khan; Raj S Padwal; Hude Quan; Alexander A Leung
Journal:  JAMA Netw Open       Date:  2019-03-01

8.  Prevalence of hypertension and blood pressure profile amongst urban-dwelling adults in Nigeria: a comparative analysis based on recent guideline recommendations.

Authors:  Njideka U Okubadejo; Obianuju B Ozoh; Oluwadamilola O Ojo; Ayesha O Akinkugbe; Ifedayo A Odeniyi; Oluseyi Adegoke; Babawale T Bello; Osigwe P Agabi
Journal:  Clin Hypertens       Date:  2019-04-15

9.  Obese and Non-obese Polycystic Ovarian Syndrome: Comparison of Clinical, Metabolic, Hormonal Parameters, and their Differential Response to Clomiphene.

Authors:  Garima Sachdeva; Shalini Gainder; Vanita Suri; Naresh Sachdeva; Seema Chopra
Journal:  Indian J Endocrinol Metab       Date:  2019 Mar-Apr

10.  Estimated Change in Prevalence of Hypertension in Nepal Following Application of the 2017 ACC/AHA Guideline.

Authors:  Gulam Muhammed Al Kibria; Krystal Swasey; Angela Kc; Mohammadhassan Mirbolouk; Muhammad Nazmus Sakib; Atia Sharmeen; Mahmuda Jahan Chadni; Kristen A Stafford
Journal:  JAMA Netw Open       Date:  2018-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.